Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,601–2,625 of 27,380 studies, newest first · page 105 of 1096.

November 2025 25

  1. 2025-11-24

    Dissecting the genetic and proteomic risk factors for delirium

    ✓ Peer-reviewed Genetics Nature Aging

    Key finding: Delirium is an acute change in cognition, common in hospitalized older adults, and associated with high healthcare and human cost; however, delirium's genetic and proteomic background remains poorly understood. +3 more findings

  2. 2025-11-24

    The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia

    ✓ Peer-reviewed Laboratory science Nature Neuroscience

    Key finding: Using a human microglia xenograft mouse model, we show that Lecanemab significantly reduces Aβ pathology and associated neuritic damage, while neither fragment crystallizable (Fc)-silenced Lecanemab nor microglia deficiency elicits this effect despite intact plaque binding. +1 more finding

  3. 2025-11-24

    Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study

    ✓ Peer-reviewed Treatments BMC Neurology

    Key finding: Overall, 392 patients were enrolled in HARMONY; 49 patients with PDD and 27 patients with DLB were included in the open-label safety analysis, of whom 46 met response criteria and were randomized to receive pimavanserin (n = 22) or placebo (n = 24) during the double-blind period. +3 more findings

  4. 2025-11-23

    Association Between Long-Term Care Insurance Certification and Early Home-Visit Nursing Frequency in Older Patients With Heart Failure in Japan

    ✓ Peer-reviewed Health systems and care delivery Home Health Care Management & Practice

    Key finding: This study examined whether LTCI certification is associated with the frequency of early home-visit nursing. +4 more findings

  5. 2025-11-23

    Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disorders

    ✓ Peer-reviewed Risk genes beyond APOE Autophagy

    Key finding: The unique spatial and functional demands of neurons result in differences in the regulation of metabolic, autophagic, mitophagic and biosynthetic processes compared to other cell types.

  6. 2025-11-23

    Blood biomarkers of Alzheimer’s disease and progression across different stages of cognitive decline in the community

    ✓ Peer-reviewed Mild cognitive impairment Nature Communications

    Key finding: Lower amyloid-β42/40 ratio and higher phosphorylated-tau181 (p-tau181), p-tau217, total-tau, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were associated with faster progression from MCI to all-cause and AD dementia, with the strongest associations for NfL and p-tau217. +2 more findings

  7. 2025-11-23
  8. 2025-11-22

    Multidomain therapy for Alzheimer’s disease: a scoping review of cognitive decline trials

    ✓ Peer-reviewed Prevention trials Molecular Neurodegeneration

    Key finding: There have been 23 studies (completed or reported as ongoing) of multidomain interventions for AD, including 19 RCTs. +4 more findings

  9. 2025-11-22
  10. 2025-11-21

    Expert consensus statement for basic research of animal exercise intervention studies in chronic disease prevention and treatment: A joint position paper of the Exercise Science branch of the Biophysical Society of China and the Metabolism and Genetics branch of the Genetics Society of China

    ✓ Peer-reviewed Prevention trials Journal of sport and health science

    Key finding: Animal exercise intervention studies are widely used and provide valuable scientific evidence about the cellular and molecular mechanisms underlying the effects of exercise training in a variety of chronic disease models. +4 more findings

  11. 2025-11-21

    Data-driven modeling of amyloid-β targeted antibodies for Alzheimer's disease

    ✓ Peer-reviewed Treatments NPJ systems biology and applications

    Key finding: Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta, which is strongly associated with disease progression and cognitive decline. +2 more findings

  12. 2025-11-21

    Additive Effects of White Matter Hyperintensity and APOE ε4 Status on Risk of Incident Dementia in Two Large Longitudinal Cohorts

    ✓ Peer-reviewed Vascular contributions Annals of Neurology

    Key finding: In ARIC (n = 1,736, mean age 63, 58.8% female, 48.7% non-Hispanic White individuals, median follow-up 18.6 years), the dementia incidence rate was 10.4 (95% CI, 9.2-11.6) per 1,000 person-years. +4 more findings

  13. 2025-11-21

    The Cognitive Functions in Patients With Postoperative Delirium Undergoing Cardiac Surgery After ICU Discharge

    ✓ Peer-reviewed Clinical safety Dimensions of Critical Care Nursing

    Key finding: Eight studies reported evidence of level 3 (OCEBM level), and 4 had high methodological quality (JBI score). +4 more findings

  14. 2025-11-21

    Polystyrene Micro- and Nanoplastic Exposure Triggers an Activation and Stress Response in Human Astrocytes

    ✓ Peer-reviewed Inflammation and the immune system International Journal of Molecular Sciences

    Key finding: Flow cytometry and confocal microscopy revealed the accumulation of particles of both sizes within the cytoplasm. +3 more findings

  15. 2025-11-21

    Endogenous Lithium Levels and Alzheimer Disease

    ✓ Peer-reviewed Treatments Clinical Chemistry

    Key finding: The pathophysiology of AD remains poorly understood, with multifactorial etiology (age, genetics, environmental, and lifestyle factors). +4 more findings

  16. 2025-11-21

    Alzheimer Disease Blood Biomarker Concentrations Across Race and Ethnicity Groups in Middle-Aged Adults

    ✓ Peer-reviewed Biomarkers JAMA Network Open

    Key finding: The sample included 4340 adults (mean [SD; range] age, 58.1 [1.1; 56-63] years; 2400 [55.3%] women); 630 (14.4%) were Black, 900 (20.7%) were Latinx, and 2610 (60.1%) were White. +4 more findings

  17. 2025-11-21

    Proteome Signature of Alzheimer-Like Phenotypes in Frontal Cortices From Young and Old Individuals With Down Syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Molecular neurobiology

    Key finding: Notably, individuals with DS exhibit significant neuropathological changes for a diagnosis of Alzheimer's disease (AD), typically by the age of 50 years. +3 more findings

  18. 2025-11-20

    TREM2 Alleviates Neuroinflammation and Improves Neurogenesis in ApoE-/- Mice by Regulating M1/M2 Microglial Polarization

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurobiology

    Key finding: Our previous study indicated that TREM2 promoted microglia polarization to the M2 phenotype in APP/PS1 transgenic mice and BV2 cells. +4 more findings

  19. 2025-11-20
  20. 2025-11-20
  21. 2025-11-20

    Effectiveness of a 52-week multidomain intervention to maintain cognitive function in patients with mild cognitive impairment: a randomized controlled trial

    ✓ Peer-reviewed Prevention trials Scientific Reports

    Key finding: We found a positive effect of the multidomain intervention using a mobile application on the change in cognitive function score in the intervention group compared to the control group at the 52-week follow-up. +2 more findings

  22. 2025-11-20

    Seeding biosensor cell line that reproduces the Alzheimer tau fold

    ✓ Peer-reviewed Disease mechanisms Journal of Biological Chemistry

    Key finding: Our results establish a sensitive biosensor cell line with specificity toward seeds from 3R + 4R tauopathies.

  23. 2025-11-20

    Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid β fibrils

    ✓ Peer-reviewed Risk genes beyond APOE Alzheimer s Research & Therapy

    Key finding: M1 specifically enhanced uptake of Aβ fibrils through reduction of intracellular cAMP levels, without affecting monomeric or oligomeric Aβ internalization. +4 more findings

  24. 2025-11-20

    Impact of assistive technologies on caregiver burden and perseverance for people with dementia at home

    ✓ Peer-reviewed Caregiving Health Policy and Technology

    Key finding: An online survey of 342 informal caregivers in the Netherlands assessed objective burden (tasks and time involved in caregiving), subjective burden (personal experience of stress and strain), current perseverance time (time expected to be able to continue providing care), and well-being (overall happiness). +3 more findings

  25. 2025-11-20

    EARLY STAGES OF ALZHEIMERS DETECTION

    ✓ Peer-reviewed Brain scans and imaging Zenodo (CERN European Organization for Nuclear Research)

    Key finding: The model is trained to recognize subtle patterns in the brain—such as structural shrinkage, texture changes, and abnormalities—associated with Alzheimer’s progression. +2 more findings

Browse the library by subject, with the full score breakdown →